A phase I trial of cisplatin (CDDP), docetaxel (DCT) and ifosfamide (IFX) in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Kunitoh, H; Sawada, M; Watanabe, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, I; Ohe, Y; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Goto, K; Hosomi, Y; Niho, S; Nishiwaki, Y; Saijo, N

• Book ID: 118569687
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 103 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80142-7